ADVFN Logo ADVFN
Donnée du Marché
Actualité
Outils
Donnée du Marché
Discover

Hot Features

Follow Feed

Rester connecter avec les traders et investisseurs dans notre communauté Follow Feed.

Flux des Options

Explorez des données complètes sur les options et utilisez les filtres avancés avec Options Flow.

Moniteur

Organisez et surveillez vos d'actions et actifs avec le Moniteur.
Se connecter Premium IconPremium Help Menu
CAC 40
8 209,28
-0,12%
Dow Jones
39 431,51
-0,21%
DAX
18 742,22
-0,08%
Brent Oil
83,21
1,00%
Bitcoin
62 874,61
2,32%
Registration Strip Icon for monitor Surveillez plusieurs cotations en temps réel des principales bourses, telles que Euronext Paris, NASDAQ, NYSE, AMEX, Bovespa et plus encore.
S'inscrire
  1. Accueil
  2. Investir
  3. Actions
  4. Royaume-Uni
  5. LSE
  6. Gt Biopharma Inc (0RU9)

  7. Gt Biopharma Inc (0RU9) Actualités

0RU9

Gt Biopharma (0RU9)

Gt Biopharma Inc
De:
Trier par:
 Showing the most relevant articles for your search:LSE:0RU9
DateHeureSourceTitreSymboleSociété
12/09/201913h30PR Newswire (US)GT Biopharma Announces FDA Notification of Commencement of Enrollment in Human GTB-3550 Trike™ Phase i/ii Clinical TrialLSE:0RU9Gt Biopharma Inc
13/06/201913h30PR Newswire (US)GT Biopharma GTB-1550LSE:0RU9Gt Biopharma Inc
29/05/201913h30PR Newswire (US)GT Biopharma GTB-1550 PHASE I-II Results to be Published in Conjunction With 2019 ASCO Meeting May 31 - June 4 in ChicagoLSE:0RU9Gt Biopharma Inc
26/03/201912h30PR Newswire (US)GT Biopharma Announces Completion of Management RestructuringLSE:0RU9Gt Biopharma Inc
30/08/201814h00PR Newswire (US)GT Biopharma's Chairman and Chief Executive Officer Raymond W Urbanski, M.D., Ph.D Provides Insight Into the Impact of the Re...LSE:0RU9Gt Biopharma Inc
29/08/201813h45PR Newswire (US)GT Biopharma's Chairman and Chief Executive Officer Provides Insight Into the Impact of the Recent Affimed/Roche-Genetech Col...LSE:0RU9Gt Biopharma Inc
24/08/201814h00PR Newswire (US)GT Biopharma Announces the Appointment of David Cardino, CPA, MBA as Vice President of FinanceLSE:0RU9Gt Biopharma Inc
14/08/201814h00PR Newswire (US)GT Biopharma Announces GTBP CEO, Dr. Raymond Urbanski, to Make Presentation at the 2018 Wedbush PacGrow Healthcare ConferenceLSE:0RU9Gt Biopharma Inc
25/07/201814h00PR Newswire (US)GT Biopharma Announces the Addition of Dr. John N. Bonfiglio to its Board of DirectorsLSE:0RU9Gt Biopharma Inc
19/07/201814h00PR Newswire (US)GT Biopharma Inc. Announces Agreement with a Major Pharmaceutical Company to Study its Drug Candidate OXS-1550 in Combination...LSE:0RU9Gt Biopharma Inc
05/06/201814h00PR Newswire (US)GT Biopharma Announces Voluntary Lock-Up Agreements With Insiders Covering Over 52% of Outstanding SharesLSE:0RU9Gt Biopharma Inc
14/05/201813h45PR Newswire (US)Gt Biopharma Announces Dr. Raymond W Urbanski Elevated to President and Chief Medical Officer of the CompanyLSE:0RU9Gt Biopharma Inc
26/04/201814h30PR Newswire (US)Seasoned Financial Executive Federica O'Brien Joins GT Biopharma's Board of DirectorsLSE:0RU9Gt Biopharma Inc
24/04/201815h15PR Newswire (US)Former Sucampo Chief Scientific Officer, Dr. Peter Kiener, Joins GT Biopharma's Board of DirectorsLSE:0RU9Gt Biopharma Inc
29/03/201815h05PR Newswire (US)GT Biopharma Inc. Announces >50% Enrollment in Proof-Of-Concept Clinical Trial For Its Novel Treatment For Motion SicknessLSE:0RU9Gt Biopharma Inc
13/02/201813h45PR Newswire (US)GT Biopharma Announces Dr. Jeffrey Miller, Renowned NK Cell Cancer Specialist, Will Present at Cell Therapy SymposiaLSE:0RU9Gt Biopharma Inc
24/01/201814h39PR Newswire (US)GT Biopharma, Inc. Issues Letter to ShareholdersLSE:0RU9Gt Biopharma Inc
18/12/201716h27PR Newswire (US)GT Biopharma, Inc. Files Application for NASDAQ Capital Market ListingLSE:0RU9Gt Biopharma Inc
 Showing the most relevant articles for your search:LSE:0RU9

Dernières Valeurs Consultées

EU
ORA
Orange
NASDAQ
GOOGL
Alphabet
EU
VIV
Vivendi
EU
AI
Air Liquide
EU
PX1
CAC 40
COIN
BTCUSD
Bitcoin
NYSE
MRK
Merck
NASDAQ
AAPL
Apple
FTSE
UKX
FTSE 100
EU
BEL20
Bel 20
EU
PX4
SBF 120
EU
BN
Danone
EU
EN
Bouygues
EU
MC
Lvmh Moet Hennessy Louis...
Delayed Upgrade Clock
ADVFN Logo

France
Société
Entreprise
Popular
Obtenir l'application

Assistance: support@advfn.fr

En accédant aux services disponibles de ADVFN, vous acceptez les Conditions Générales de ADVFN Conditions Générales

© 2024 ADVFN PLC - Tous droits réservés